SVG
Accelerating Innovation
Featured
Report
The Future of US Biomedical Research and Innovation: Recommendations for Action
The United States biomedical research and innovation enterprise has long been a source of global leadership, scientific...
Read
Report
Featured
Report
The Future of US Biomedical Research and Innovation: Recommendations for Action
The United States biomedical research and innovation enterprise has long been a source of global leadership, scientific...
Read
Report
SVG
Accelerating Innovation
Programs
Removing barriers to innovations that hold great promise for patients, and facilitating dialogue on the path forward for new technologies
Cell and Gene Therapy
Cell and gene therapies are transforming how we can treat and potentially cure disease.
Emerging Technologies
Health data fuel biomedical innovation. Data-driven patient participation—that is, patient contribution of their biospecimens...
Oncology
Amplifying new approaches and developments affecting the field of oncology and address barriers to their innovation.
Accelerating Innovation
Highlights
-
The Future of US Biomedical Research and Innovation: Recommendations for Action
The United States biomedical research and innovation enterprise has long been a source of global leadership, scientific breakthroughs, and lifesaving treatments. Decades of investments in research and development have positioned the US as...Read ReportThe United States biomedical research and innovation enterprise has long been a source of global leadership, scientific breakthroughs, and lifesaving treatments.
-
A Pivotal Role: Liquid Biopsies in the Future of Cancer Care
Cancer care is entering a new era. Despite decades of investment and remarkable breakthroughs, the disease continues to affect millions of people each year—and those numbers are rising. In the United States, new cancer cases are expected to...Read Report
-
Tech Regulation Digest: Biden Administration Moves on AI Regulation
Overview On October 30, 2023, President Joe Biden signed an executive order that establishes new federal standards and regulations for the safe and ethical use of artificial intelligence (AI). Covering a wide set of sectors potentially...Read ArticleLJ
-
The Impact of Insight: Patient Preferences in Novel Screening Technologies for Cancer
Patient preferences and insights are increasingly considered throughout the medical product life cycle in addition to clinical outcomes. We know that incorporating patient preferences in the product life cycle can create meaningful results...Read ReportPatient preferences and insights are increasingly considered throughout the medical product life cycle in addition to clinical outcomes. We know that incorporating patient preferences in the product...
KO
-
Mapping the Journey: Building a Mutual Understanding for Health Equity in Clinical Research
If the objective of biomedical research is to spur innovation to create healthier communities, extend life, and more effectively treat or cure disease, then persistent inequities run counter to that goal and create unnecessary barriers to...Read Report
KO
-
Landscape of Trust: Health Data Frameworks
The rapid advancement of the health technology landscape relies heavily on patient data. Patient data from medical records and digital health apps can be leveraged to build new tools that can help diagnose disease, remotely monitor and...Read ReportJM
-
Strengthening the Biomedical Innovation Ecosystem: A Scorecard for System Assessment
As patients, we often evaluate our interactions within the "system" of biomedical innovation with a simple question: "Did it work for me?" This evaluation considers many issues, including whether the best treatments are accessible and...Read ReportAD
SG
-
Cell and Gene Therapies: Looking Ahead to 2022
Cell and gene therapies are a new category of medicines transforming how we treat and potentially cure disease. Both cell and gene therapies seek to modify genetic material to fight disease. Cell therapies involve cultivating or modifying...Read Report
-
Achieving Health Equity: A Multi-Stakeholder Action Plan to Address Diversity across the Clinical Trials Enterprise and the Biomedical Research Ecosystem
Clinical trials have been used for decades as the primary way by which researchers determine if a new treatment is safe and effective for human use. Within the biomedical research ecosystem, participants in clinical trials often do not...Read Report